Heron Therapeutics annual debt-to-equity ratio
2019
2020
2021
2022
2025
Heron Therapeutics Debt-to-Equity Ratio Growth & History (HRTX)
Heron Therapeutics's debt-to-equity ratio was 0.00 for fiscal 2025.
View full Heron Therapeutics company overviewHeron Therapeutics annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.00 | — | — |
| 2022 | 2022-12-31 | 0.60 | 0.47 | +349.69% |
| 2021 | 2021-12-31 | 0.13 | 0.06 | +80.81% |
| 2020 | 2020-12-31 | 0.07 | 0.04 | +111.62% |
| 2019 | 2019-12-31 | 0.04 | — | — |
Heron Therapeutics quarterly debt-to-equity ratio
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q3.22
Q4.22
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.83 | — | — |
| Q1 2026 | 2026-03-31 | 0.00 | — | — |
| Q4 2025 | 2025-12-31 | 0.00 | — | — |
| Q3 2025 | 2025-09-30 | 0.05 | — | — |
| Q4 2022 | 2022-12-31 | 0.60 | 0.47 | +349.69% |
| Q3 2022 | 2022-09-30 | 0.39 | 0.26 | +200.17% |
| Q1 2022 | 2022-03-31 | 0.41 | 0.33 | +379.40% |
| Q4 2021 | 2021-12-31 | 0.13 | 0.06 | +80.81% |
| Q3 2021 | 2021-09-30 | 0.13 | 0.06 | +98.09% |
| Q2 2021 | 2021-06-30 | 0.10 | 0.04 | +73.75% |
| Q1 2021 | 2021-03-31 | 0.09 | 0.03 | +61.45% |
| Q4 2020 | 2020-12-31 | 0.07 | 0.04 | +111.62% |
| Q3 2020 | 2020-09-30 | 0.07 | 0.02 | +49.99% |
| Q2 2020 | 2020-06-30 | 0.06 | 0.02 | +36.86% |
| Q1 2020 | 2020-03-31 | 0.05 | 0.01 | +28.47% |
| Q4 2019 | 2019-12-31 | 0.04 | — | — |
| Q3 2019 | 2019-09-30 | 0.04 | — | — |
| Q2 2019 | 2019-06-30 | 0.04 | — | — |
| Q1 2019 | 2019-03-31 | 0.04 | — | — |
Heron Therapeutics debt-to-equity ratio trends
Over the last five fiscal years, Heron Therapeutics's debt-to-equity ratio decreased from 0.07 to 0.00, a change of −0.07. The latest reported quarter, Q2 2026, shows 0.83.
About the metric
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
Calculation and source
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Heron Therapeutics source filings ↗